Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: The BC cancer agency experience

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 4, 2013, Pages 719-725

  Hamilton, Sarah N ^a,b   Wai, Elaine S ^b   Tan, King ^b   Alexander, Cheryl ^b   Gascoyne, Randy D ^a,b   Connors, Joseph M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B-CELL LYMPHOMA; CLINICAL CHARACTERISTICS; COX REGRESSION ANALYSIS; DIFFUSE LARGE B CELLS; DISEASE-SPECIFIC SURVIVALS; IN-FIELD RECURRENCE; MARGINAL ZONE; METHODS AND MATERIALS;

CHEMOTHERAPY; DISEASES; ONCOLOGY; REGRESSION ANALYSIS; SURGERY;

DIAGNOSIS;

BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RESEARCH; CLINICAL FEATURE; CONTROLLED STUDY; CUTANEOUS B CELL LYMPHOMA; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLICLE CENTER CELL CARCINOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PATHOLOGIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN LYMPHOMA; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDNISONE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84886095852     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.07.019     Document Type: Article

References (23)

1. P. Bradford, S. Devesa, and W. Anderson Cutaneous lymphoma incidence pattern in the United States: A population-based study of 3884 Blood 113 2009 5064 5073
2. A. Gillis, T. Bui, and M. Roach Cutaneous lymphomas E. Hansen, M. Roach, Handbook of Evidence-Based Radiation Oncology 2nd ed 2010 Springer New York 593 598
3. T. Habermann, and M. Pittelkow Cutaneous T-cell lymphoma and cutaneous B-cell lymphoma M. Abeloff, J. Armitage, J. Niederhuber, Clinical Oncology 4th ed 2008 Churchill Livingstone Elsevier Philadelphia 2405
4. B. Smith, G. Smith, and D. Cooper The Cutaneous B-Cell Lymphoma Prognostic Index: A novel prognostic index derived from a population-based registry J Clin Oncol 23 2005 3390 3395
5. R. Willemze, E. Jaffe, and G. Burg WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3775
6. R. Willemze Primary cutaneous B-cell lymphoma: Classification and treatment Curr Opin Oncol 18 2006 425 431
7. T. Hembury, B. Lee, and R. Gascoyne Primary cutaneous diffuse large B-cell lymphoma: A clinicopathologic study of 15 cases Am J Clin Pathol 117 2002 574 580
8. L. Cerroni, N. Zöchling, and B. Pütz Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma J Cutan Pathol 24 1997 457 461
9. G. Wood, N. Kamath, and J. Guitart Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States J Cutan Pathol 28 2001 502 507
10. M. Oken, R. Creech, and D. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
11. N. Senff, J. Hoefnagel, and P. Jansen Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: Comparison with previous classifications and identification of prognostic markers J Clin Oncol 25 2007 1581 1587
12. M. Mian, M. Marcheselli, and L. Luminari CLIPI: A new prognostic index for indolent cutaneous B cell lymphoma proposed by the international extranodal lymphoma study group (IELSG 11) Ann Hematol 90 2011 401 408
13. P. Zinzani, P. Quaglino, and N. Pimpinelli Prognostic factors in primary cutaneous B-cell lymphoma: The Italian study group for cutaneous lymphomas J Clin Oncol 24 2006 1376 1382
14. F. Grange, E. Maubec, and M. Bagot Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab Arch Dermatol 145 2009 329 330
15. S. Reddy, Y. Kim, and R. Advani Confirmation of the prognostic value of the EORTC/WHO classification of primary cutaneous B-cell lymphoma in the United States: The Stanford University experience [abstract] J Clin Oncol 25 2007 8028
16. I. Mirza, N. Macpherson, and S. Paproski Primary cutaneous follicular lymphoma: An assessment of clinical, histopathologic, immunophenotypic, and molecular features J Clin Oncol 20 2002 647 655
17. H.T. Eich, D. Eich, and O. Micke Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma Int J Radiat Oncol Biol Phys 55 2003 899 906
18. R. Fink-Puches, I.H. Wolf, and I. Zalaudek Treatment of primary cutaneous B-cell lymphoma with rituximab J Am Acad Dermatol 52 2005 847 853
19. S. Gellrich, J.M. Muche, and A. Wilks Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphoma: An applicational observation Br J Dermatol 153 2005 167 173
20. L.M. Heinzerling, M. Urbanek, and J.O. Funk Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma Cancer 89 2000 1835 1844
21. K. Kodama, C. Massone, and A. Chott Primary cutaneous large B-cell lymphomas: Clinicopathologic features, classification, and prognostic factors in a large series of patients Blood 106 2005 2491 2497
22. M. Pfreundschuh, L. Trümper, and A. Osterborg CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 2006 379 391
23. P. Feugier, A. Van Hoof, and P. Sebban Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'Adulte J Clin Oncol 23 2005 4117 4226